Medytox Global Business Center focuses on maximizing synergy by managing each business unit and plays a role as a global business center by managing plants in Korea including Seoul, Suwon, Osong, and Ochang and overseas corporations in Japan, Thailand, Taiwan, and Hong Kong.

Medytox R&D Center (Gwanggyo) is a 13-story biolab (with 5 stories underground & 8 stories) equipped with state-of-the-art research facilities and world-class research infrastructure. The unique characteristic lies in constructing one-stop R&D system, in which one can do all possible research in one location to create innovative and noteworthy research outcomes.

Medytox R&D Center (Osong) is a research institute that has built the best researchers and R&D facilities for the development of the world's best botulinum toxin formulation. Currently,we are conducting various studies for commercialization of products such as the development of botulinum toxin, process development, and the establishment of strain banks.

Medytox Plant I (in Ochang), Korea’s first botulinum toxin type A manufacturing facility, is designed as a dedicated facility for the manufacture of botulinum toxin and finished products. It obtained GMP approval for biologics and injectables from the MFDS.

Medytox Plant II (in Osong) is designed to meet the cGMP standards of the U.S. FDA and GMP standards of the European EMA. It will serve as a production facility for liquid-type botulinum toxin type A(MT10109L).

Medytox Plant III (in Osong) is a state-of-the-art facility designed to produce botulinum toxin type A and hyaluronic acid filler products to meet the growing global demand. Medytox Plant III is a cGMP/EU GMP compliant facility for the production of both botulinum toxin and HA filler products. It obtained KGMP approval for its botulinum toxin production facility in 2016 and its filler production facility in 2018. In November 2024, Medytox obtained KGMP approval for Medytox Plant III E-wing, a large-scale production line equipped with state-of-the-art technology.

NUMECO Inc., a domestic sales corporation including a business model specialized in botulinum toxin products and fillers, was established in 2013. With systematic management system and expertise in marketing and sales, we will grow as a company that will lead the domestic market with our customers.